(19)
(11) EP 4 326 229 A1

(12)

(43) Date of publication:
28.02.2024 Bulletin 2024/09

(21) Application number: 22728285.2

(22) Date of filing: 23.05.2022
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 8/00(2006.01)
A61K 31/728(2006.01)
 A61K 9/127(2006.01)
A61P 1/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/728; A61K 9/0048; A61K 9/1271; A61K 47/36; A61K 8/14; A61K 8/735; A61K 8/73; A61Q 19/00; A61K 31/715; A61P 27/02; A61P 27/04
 
C-Sets:
  1. A61K 31/715, A61K 2300/00;
  2. A61K 31/728, A61K 2300/00;
(86) International application number:
PCT/IB2022/054800
(87) International publication number:
WO 2022/249028 (01.12.2022 Gazette 2022/48)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 27.05.2021 IT 202100013787

(71) Applicant: FARMIGEA S.P.A.
56121 Pisa (IT)

(72) Inventors:
  • SANSÒ, Marco Aldo
    56121 Pisa (IT)
  • NEGGIANI, Fabio
    56121 Pisa (IT)

(74) Representative: Villa, Livia 
ADV IP S.r.l. Corso di Porta Vittoria 29
20122 Milano
20122 Milano (IT)

   


(54) A COMPOSITION FOR USE IN THE TREATMENT OF OCULAR AFFECTIONS, SUCH AS DRY EYE DISEASE, ESPECIALLY AFTER EYE SURGERY